PIK3CA and breast carcinoma: These results demonstrate that the PIK3CAH1047R mutation can initiate heterogeneous breast cancers by triggering the MaSC genetic program in differentiated BCs and LCs, thus providing new insights into the development of therapeutic strategies for PI3K-related breast cancers.